When to transfuse your acute care patient? A narrative review of the risk of anemia and red blood cell transfusion based on clinical trial outcomes;Quand transfuser un patient en soins aigus? Un compte rendu narratif du risque de l’anémie et de la transfusion d’érythrocytes selon les résultats des études cliniques

Canadian Journal of Anesthesia

Volumn 67, Issue 11, 2020, Pages 1576-1594

  Hare, Gregory M T ^a,b,c   Cazorla Bak, Melina P ^a,b,c   Ku, S F Michelle ^a   Chin, Kyle ^a,c   Mistry, Nikhil ^a,b   Sklar, Michael C ^a,b   Pavenski, Katerina ^a,d   Alli, Ahmad ^a   Van Rensburg, Adriaan ^e   Friedrich, Jan O ^a,b,c   Baker, Andrew J ^a,b,c   Mazer, C David ^a,b,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

anemia; patient blood management; Perioperative risk; randomized trials; transfusion

Indexed keywords

HEMOGLOBIN;

ANEMIA; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CLINICAL EVALUATION; COMORBIDITY; DISEASE ASSOCIATION; ERYTHROCYTE TRANSFUSION; HEART SURGERY; HEMODILUTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTENSIVE CARE; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; THERAPY EFFECT; TREATMENT OUTCOME; ADVERSE EVENT; BLOOD TRANSFUSION; CRITICAL ILLNESS;

ANEMIA; BLOOD TRANSFUSION; CRITICAL CARE; CRITICAL ILLNESS; ERYTHROCYTE TRANSFUSION; HEMOGLOBINS; HUMANS;

EID: 85089190931     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-020-01763-9     Document Type: Review

References (111)

1. Carson J, Poses RM, Spence RK, Bonavita G. Severity of anaemia and operative mortality and morbidity. Lancet 1988; 1: 727-9.
2. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348: 1055-60.
3. Fang WC, Helm RE, Krieger KH, et al. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 1997; 96(9 Suppl): II-194-9.
4. Guinn NR, Cooter ML, Villalpando C, Weiskopf RB. Severe anemia associated with increased risk of death and myocardial ischemia in patients declining blood transfusion. Transfusion 2018; 58: 2290-6.
5. Karkouti K, Wijeysundera DN, Beattie WS; Reducing Bleeding in Cardiac Surgery (RBC) Investigators. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008; 117: 478-84.
6. Kulier A, Levin J, Moser R, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007; 116: 471-9.
7. Government of Canada, Public Health Agency of Canada. Transfusion Transmitted Injuries Surveillance System, 2006-2012 Summary Results; 2014. Available from URL: www.canada.ca (accessed May 2020).
8. Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004; 44: 1453-62.
9. Koch CG, Li L, Duncan AI, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006; 34: 1608-16.
10. Shander A, Javidroozi M, Ozawa S, Hare GM. What is really dangerous: anaemia or transfusion? Br J Anaesth 2011; 107: i41-59.
11. Hare GM, Freedman J, Mazer CD. Risks of anemia and related management strategies: can perioperative blood management improve patient safety? Can J Anesth 2013; 60: 168-75.
12. Nalla BP, Freedman J, Hare GM, Mazer CD. Update on blood conservation for cardiac surgery. J Cardiovasc Thorac Anesth 2012; 26: 117-33.
13. Yanagawa B, Rocha RV, Mazine A, et al. hemoglobin optimization for coronary bypass: a 10-year Canadian multicenter experience. Ann Thorac Surg 2019; 107: 711-7.
14. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 2016; DOI: 10.1371/journal.pbio.1002533. DOI: 10.1371/journal.pbio.1002533
15. Poskitt EM. Early history of iron deficiency. Br J Haematol 2003; 122: 554-62.
16. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity 2011. Available from URL: https://www.who.int/vmnis/indicators/haemoglobin/en/ (accessed May 2020).
17. Fowler AJ, Ahmad T, Abbott TE, et al. Association of preoperative anaemia with postoperative morbidity and mortality: an observational cohort study in low-, middle-, and high-income countries. Br J Anaesth 2018; 121: 1227-35.
18. Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 2014; 123: 615-24.
19. Global Burden of Disease Pediatrics Collaboration; Kyu H, Pinho C, Wagner JA, et al. Global and National Burden of Diseases and injuries among children and adolescents between 1990 and 2013: findings from the Global Burden of Disease 2013 study. JAMA Pediatr 2016; 170: 267-87.
20. Scott SP, Chen-Edinboro LP, Caulfield LE, Murray-Kolb LE. The impact of anemia on child mortality: an updated review. Nutrients 2014; 6: 5915-32.
21. Daru J, Zamora J, Fernandez-Felix BM, et al. Risk of maternal mortality in women with severe anaemia during pregnancy and post partum: a multilevel analysis. Lancet Glob Health 2018; 6: e548-54.
22. Penninx BW, Pahor M, Woodman RC, Guralnik JM. Anemia in Old Age Is Associated With Increased Mortality and Hospitalization. J Gerentol A Biol Sci Med Sci 2006; 61: 474-9.
23. Mueller MM, Van Remoortel H, Meybohm P, et al. Patient blood management: recommendations from the 2018 Frankfurt Consensus Conference. JAMA 2019; 321: 983-97.
24. Fowler AJ, Ahmad T, Phull MK, Allard S, Gillies MA, Pearse RM. Meta-analysis of the association between preoperative anaemia and mortality after surgery. Br J Surg 2015; 102: 1314-24.
25. Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1396-407.
26. Klein AA, Collier TJ, Brar MS, et al. The incidence and importance of anaemia in patients undergoing cardiac surgery in the UK - the first Association of Cardiothoracic Anaesthetists national audit. Anaesthesia 2016; 71: 627-35.
27. Padmanabhan H, Brookes MJ, Nevill AM, Luckraz H. Association between anemia and blood transfusion with long-term mortality after cardiac surgery. Ann Thorac Surg 2019; 108: 687-92.
28. Padmanabhan H, Siau K, Curtis J, et al. Preoperative anemia and outcomes in cardiovascular surgery: systematic review and meta-analysis. Ann Thorac Surg 2019; 108: 1840-8.
29. Beattie WS, Wijeysundera DN, Karkouti K, et al. Acute surgical anemia influences the cardioprotective effects of β-blockade: a single-center, propensity-matched cohort study. Anesthesiology 2010; 112: 25-33.
30. Beattie WS, Karkouti K, Wijeysundera DN, Tait G. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology 2009; 110: 574-81.
31. Ragoonanan TE, Beattie WS, Mazer CD, et al. Metoprolol reduces cerebral tissue oxygen tension after acute hemodilution in rats. Anesthesiology 2009; 111: 988-1000.
32. McLaren AT, Marsden PA, Mazer CD, et al. Increased expression of HIF-1α, nNOS, and VEGF in the cerebral cortex of anemic rats. Am J Physiol Regul Integr Comp Physiol 2007; 292: R403-14.
33. Hare GM, Mazer CD, Mak W, et al. Hemodilutional anemia is associated with increased cerebral neuronal nitric oxide synthase gene expression. J Appl Physiol 1985; 2003(94): 2058-67.
34. Tsui AK, Marsden PA, Mazer CD, et al. Priming of hypoxia-inducible factor by neuronal nitric oxide synthase is essential for adaptive responses to severe anemia. Proc Natl Acasd Sci USA 2011; 108: 17544-9.
35. Tsui AK, Marsden PA, Mazer CD, et al. Differential HIF and NOS responses to acute anemia: defining organ-specific hemoglobin thresholds for tissue hypoxia. Am J Physiol Regul Integr Comp Physiol. 2014; 307: R13-25.
36. Loor G, Li L, Sabik JF 3rd, Rajeswaran J, Blackstone EH, Koch CG. Nadir hematocrit during cardiopulmonary bypass: end-organ dysfunction and mortality. J Thorac Cardiovasc Surg 2012; 144(654–62): e4.
37. Karkouti K, Beattie WS, Wijeysundera DN, et al. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg 2005; 129: 391-400.
38. Mistry N, Mazer CD, Sled JG, et al. Red blood cell antibody-induced anemia causes differential degrees of tissue hypoxia in kidney and brain. Am J Physiol Regul Integr Comp Physiol 2018; 314: R611-22.
39. El Beheiry MH, Heximer SP, Voigtlaender-Bolz J, et al. Metoprolol impairs resistance artery function in mice. J Appl Physiol 1985; 2011(111): 1125-33.
40. Hu T, Beattie WS, Mazer CD, et al. Treatment with a highly selective beta(1) antagonist causes dose-dependent impairment of cerebral perfusion after hemodilution in rats. Anesth Analg 2013; 116: 649-62.
41. Hare GM, Worrall JM, Baker AJ, Liu E, Sikich N, Mazer CD. Beta2 adrenergic antagonist inhibits cerebral cortical oxygen delivery after severe haemodilution in rats. Br J Anaesth 2006; 97: 617-23.
42. Karkouti K, Djaiani G, Borger MA, et al. Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Annal Thorac Surg 2005; 80: 1381-7.
43. Swaminathan M, Phillips-Bute BG, Conlon PJ, Smith PK, Newman MF, Stafford-Smith M. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Annal Thorac Surg 2003; 76: 784-91.
44. Karkouti K, Wijeysundera DN, Yau TM, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009; 119: 495-502.
45. Cook DJ, Orszulak TA, Daly RC, MacVeigh I. Minimum hematocrit for normothermic cardiopulmonary bypass in dogs. Circulation 1997; 96(Suppl 9): II-200-4.
46. Homi HM, Yang H, Pearlstein RD, Grocott HP. Hemodilution during cardiopulmonary bypass increases cerebral infarct volume after middle cerebral artery occlusion in rats. Anesth Analg 2004; 99: 974-81.
47. Kumar AB, Suneja M, Bayman EO, Weide GD, Tarasi M. Association between postoperative acute kidney injury and duration of cardiopulmonary bypass: a meta-analysis. J Cardiovasc Thorac Surg 2012; 26: 64-9.
48. Abrahamson JR, Read A, Chin K, et al. Renal tissue PO2 sensing during acute hemodilution is dependent on the diluent. Am J Physiol Regul Integr Comp Physiol 2020; DOI: 10.1152/ajpregu.00323.2019. DOI: 10.1152/ajpregu.00323.2019
49. Johannes T, Mik EG, Nohe B, Unertl KE, Ince C. Acute decrease in renal microvascular PO2 during acute normovolemic hemodilution. Am J Physiol Renal Physiol 2007; 292: F796-803.
50. Darby PJ, Kim N, Hare GM, et al. Anemia increases the risk of renal cortical and medullary hypoxia during cardiopulmonary bypass. Perfusion 2013; 28: 504-11.
51. Mazer CD, Briet F, Blight KR, et al. Increased cerebral and renal endothelial nitric oxide synthase gene expression after cardiopulmonary bypass in the rat. J Thorac Cardiovasc Surg 2007; 133: 13-20.
52. Souma T, Suzuki N, Yamamoto M. Renal erythropoietin-producing cells in health and disease. Front Physiol 2015; DOI: 10.3389/fphys.2015.00167. DOI: 10.3389/fphys.2015.00167
53. Zhu MZ, Martin A, Cochrane AD, et al. Urinary hypoxia: an intraoperative marker of risk of cardiac surgery-associated acute kidney injury. Nephrol Dial Transplant 2018; 33: 2191-201.
54. Hare GM, Han K, Leshchyshyn Y, et al. Potential biomarkers of tissue hypoxia during acute hemodilutional anemia in cardiac surgery: a prospective study to assess tissue hypoxia as a mechanism of organ injury. Can J Anesth 2018; 65: 901-13.
55. Iguchi N, Kosaka J, Booth LC, et al. Renal perfusion, oxygenation, and sympathetic nerve activity during volatile or intravenous general anaesthesia in sheep. Br J Anaesth 2019; 122: 342-9.
56. Lankadeva YR, Cochrane AD, Marino B, et al. Strategies that improve renal medullary oxygenation during experimental cardiopulmonary bypass may mitigate postoperative acute kidney injury. Kidney Int 2019; 95: 1338-46.
57. Lankadeva YR, Kosaka J, Evans RG, Bellomo R, May CN. Urinary oxygenation as a surrogate measure of medullary oxygenation during angiotensin II therapy in septic acute kidney injury. Crit Care Med 2018; 46: e41-8.
58. Tan CC, Eckardt KU, Firth JD, Ratcliffe PJ. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol 1992; 263(3 Pt 2): F474-81.
59. Koury ST, Koury MJ, Bondurant MC, Caro J, Graber SE. Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 1989; 74: 645-51.
60. Friedman MT, Avadhani V, Gilmore S, Madrigal E. Blood transfusion in the 21st century. Discoveries 2014; DOI: 10.15190/d.2014.3. DOI: 10.15190/d.2014.3
61. Elsom DM, Webb J. Deaths and injuries from lightning in the UK, 1988–2012. Weather 2014; DOI: 10.1002/wea.2254. DOI: 10.1002/wea.2254
62. Working Expert Group (WEG) & Writing Group, on behalf of the SHOT Steering Group. Annual SHOT Report - 2018. Available from URL: https://www.shotuk.org/wp-content/uploads/myimages/SHOT-Report-2018_Web_Version-1.pdf (accessed May 2020).
63. Food and Drug Association. Transfusion/Donation Fatalities. Available from URL: https://www.fda.gov/vaccines-blood-biologics/report-problem-center-biologics-evaluation-research/transfusiondonation-fatalities (accessed May 2020).
64. Harvey AR, Basavaraju SV, Chung KW, Kuehnert MJ. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012. Transfusion 2015; 55: 709-18.
65. Ditomasso J, Liu Y, Heddle NM. The Canadian Transfusion Surveillance System: what is it and how can the data be used? Transfus Apher Sci 2012; 46: 329-35.
66. Mazer CD, Whitlock RP, Fergusson DA, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med 2017; 377: 2133-44.
67. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-62.
68. Murphy GJ, Pike K, Rogers CA, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015; 372: 997-1008.
69. Callum JL, Pinkerton PH, Lima A, et al. Bloody Easy 4. Blood Transfusions, Blood Alternatives and Transfusion Reactions. A Guide to Transfusion Medicine, Fourth Edition. Ontario Regional Blood Coordinating Network 2016.
70. Patel NN, Avlonitis VS, Jones HE, Reeves BC, Sterne JA, Murphy GJ. Indications for red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis. Lancet Haematol 2015; 2: e543-53.
71. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT study: anemia and blood transfusion in the critically ill–current clinical practice in the United States. Crit Care Med 2004; 32: 39-52.
72. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499-507.
73. Mazer CD, Whitlock RP, Fergusson DA, et al. Six-month outcomes after restrictive or liberal transfusion for cardiac surgery. N Engl J Med 2018; 379: 1224-33.
74. Hovaguimian F, Myles PS. Restrictive versus liberal transfusion strategy in the perioperative and acute care settings. A context-specific systematic review and meta-analysis of randomized controlled trials. Anesthesiology 2016; 125: 46-61.
75. Hébert PC, Carson JL. Transfusion threshold of 7 g per deciliter—the new normal. N Engl J Med 2014; 371: 1459-61.
76. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-17.
77. McIntyre LA, Fergusson DA, Hutchison JS, et al. Effect of a liberal versus restrictive transfusion strategy on mortality in patients with moderate to severe head injury. Neurocrit Care 2006; 5: 4-9.
78. Hébert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001; 29: 227-34.
79. Bergamin FS, Almeida JP, Landoni G, et al. Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the transfusion requirements in critically ill oncologic patients randomized controlled trial. Crit Care Med 2017; 45: 766-73.
80. Carson JL, Brooks MM, Abbott JD, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J 2013; 165(964–71): e1.
81. Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014; 371: 1381-91.
82. Jairath V, Kahan BC, Gray A, et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet 2015; 386: 137-44.
83. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21.
84. Gregersen M, Borris LC, Damsgaard EM. Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: the TRIFE randomized controlled trial. Acta Orthop 2015; 86: 363-72.
85. Grover M, Talwalkar S, Casbard A, et al. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang 2006; 90: 105-12.
86. Bracey AW, Radovancevic R, Riggs SA, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 1999; 39: 1070-7.
87. Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010; 304: 1559-67.
88. Koch CG, Sessler DI, Mascha EJ, et al. A randomized clinical trial of red blood cell transfusion triggers in cardiac surgery. Ann Thorac Surg 2017; 104: 1243-50.
89. Simon GI, Craswell A, Thom O, Fung YL. Outcomes of restrictive versus liberal transfusion strategies in older adults from nine randomised controlled trials: a systematic review and meta-analysis. Lancet Haematol 2017; 4: e465-74.
90. Simon GI, Craswell A, Thom O, Chew MS, Anstey CM, Fung YL. Impacts of aging on anemia tolerance, transfusion thresholds, and patient blood management. Transfus Med Rev 2019; 33: 154-61.
91. Kashani HH, Lodewyks C, Kavosh MS, et al. The effect of restrictive versus liberal transfusion strategies on longer-term outcomes after cardiac surgery: a systematic review and meta-analysis with trial sequential analysis. Can J Anesth 2020; 67: 577-87.
92. Kei T, Mistry N, Curley G, et al. Efficacy and safety of erythropoietin and iron therapy to reduce red blood cell transfusion in surgical patients: a systematic review and meta-analysis. Can J Anesth 2019; 66: 716-31.
93. Cho BC, Serini J, Zorrilla-Vaca A, et al. Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients: results from a systematic review and meta-analysis. Anesth Analg 2019; 128: 981-92.
94. Chen N, Hao C, Peng X, et al. Roxadustat for anemia in patients with kidney disease not receiving dialysis. N Engl J Med 2019; 381: 1001-10.
95. Shander A, Bracey AW Jr, Goodnough LT, et al. Patient blood management as standard of care. Anesth Analg 2016; 123: 1051-3.
96. Anthes E. Evidence-based medicine: save blood, save lives. Nature 2015; 520: 24-6.
97. Kaserer A, Rossler J, Braun J, et al. Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. Anaesthesia 2019; 74: 1534-41.
98. Shander A, Goodnough LT. From tolerating anemia to treating anemia. Ann Intern Med 2019; 170: 125-6.
99. Goodnough LT, Shander A. Patient blood management. Anesthesiology 2012; 116: 1367-76.
100. Spahn DR, Schoenrath F, Spahn GH, et al. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. Lancet 2019; 393: 2201-12.
101. Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993; 34: 216-22.
102. Van den Brink WA, van Santbrink H, Steyerberg EW, et al. Brain oxygen tension in severe head injury. Neurosurgery 2000; 46: 868-76; discussion 876-8.
103. Valadka AB, Gopinath SP, Contant CF, Uzura M, Robertson CS. Relationship of brain tissue PO2 to outcome after severe head injury. Crit Care Med 1998; 26: 1576-81.
104. Oddo M, Levine JM, Kumar M, et al. Anemia and brain oxygen after severe traumatic brain injury. Intensive Care Med 2012; 38: 1497-504.
105. Hare GM, Mazer CD, Hutchison JS, et al. Severe hemodilutional anemia increases cerebral tissue injury following acute neurotrauma. J Appl Physiol 1985; 2007(103): 1021-9.
106. Baker AJ, Park E, Hare GM, Liu E, Sikich N, Mazer DC. Effects of resuscitation fluid on neurologic physiology after cerebral trauma and hemorrhage. J Trauma 2008; 64: 348-57.
107. Chesnut R, Aguilera S, Buki A, et al. A management algorithm for adult patients with both brain oxygen and intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC). Intensive Care Med 2020; DOI: 10.1007/s00134-019-05900-x. DOI: 10.1007/s00134-019-05900-x
108. Okonkwo DO, Shutter LA, Moore C, et al. Brain oxygen optimization in severe traumatic brain injury phase-II: a phase II randomized trial. Crit Care Med 2017; 45: 1907-14.
109. Robertson CS, Hannay HJ, Yamal JM, et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA 2014; 312: 36-47.
110. Salim A, Hadjizacharia P, DuBose J, et al. Role of anemia in traumatic brain injury. J Am Coll Surg 2008; 207: 398-406.
111. Utter GH, Shahlaie K, Zwienenberg-Lee M, Muizelaar JP. Anemia in the setting of traumatic brain injury: the arguments for and against liberal transfusion. J Neurotrauma 2011; 28: 155-65.